Skip to main content
. 2023 May 17;14:973930. doi: 10.3389/fendo.2023.973930

Figure 11.

Figure 11

Validation of signature genes in clinical samples. (A) Immunofluorescence results of FGF9-Vimentin, IL1R2-Vimentin and NID2-Vimentin. (B) Immunofluorescence results of CFB-CX3CR1, CXCL11-CX3CR1 and NID2-CX3CR1. *represents P<0.05, compared with the control group; Here, Vimentin representative decidual stromal cell, CX3CR1 representative macrophage; Scale bar: 50μm.